Combined subchondral and intra-articular injections of bone marrow aspirate concentrate provide stable results up to 24 months.

Elizaveta KonAngelo BoffaLuca AndrioloAlessandro Di MartinoBerardo Di MatteoNicola MagarelliNicoletta TrentiStefano ZaffagniniGiuseppe Filardo

Published in: Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA (2022)

Combined intra-articular and subchondral BMAC injections provided clinical and imaging benefits up to 24 months for the treatment of symptomatic knee OA, with durable clinical results, a low failure rate, and a significant reduction of bone marrow edema.

Keyphrases

bone marrow
mesenchymal stem cells
knee osteoarthritis
high resolution
total knee arthroplasty
platelet rich plasma
photodynamic therapy
anterior cruciate ligament reconstruction